Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

DKB Fonds - Pharma Fonds

+ Add to Watchlist

DKBPHAR:LX

66.33 EUR 0.19 0.29%

As of 09:45:00 ET on 05/22/2015.

Snapshot for DKB Fonds - Pharma Fonds (DKBPHAR)

Year To Date: +18.93% 3-Month: +7.74% 3-Year: +30.41% 52-Week Range: 45.17 - 69.44
1-Month: -3.23% 1-Year: +50.47% 5-Year: +21.94% Beta vs MSGUHC: 0.89

Mutual Fund Chart for DKBPHAR

No chart data available.
  • DKBPHAR:LX 66.33
  • 1M
  • 1Y
Interactive DKBPHAR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DKBPHAR

DKB Pharma Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term growth. The Fund invests in equities issued by pharmaceutical, technology and biotechnology companies in North America and Europe.

Inception Date: 11-22-1999 Telephone: 352-424345464
Managers: MARKUS HAMELLA
Web Site: www.bayerninvest.lu

Fundamentals for DKBPHAR

NAV (on 2015-05-22) 66.33
Assets (M) (on 2015-05-22) 44.67
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DKBPHAR

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2015-05-20) 0.67
Dividend Yield (ttm) 1.01

Fees & Expenses for DKBPHAR

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.40
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.82

Top Fund Holdings for DKBPHAR

Filing Date: 04/30/2015
Name Position Value % of Total
Novartis AG 32,933 3,041,189 6.387%
Pfizer Inc 85,500 2,650,450 5.566%
Roche Holding AG 7,850 2,012,046 4.225%
Merck & Co Inc 36,000 1,942,304 4.079%
Sanofi 18,000 1,648,080 3.461%
Gilead Sciences Inc 17,100 1,581,767 3.322%
AbbVie Inc 22,500 1,334,968 2.803%
Amgen Inc 8,900 1,295,233 2.720%
GlaxoSmithKline PLC 61,400 1,293,987 2.717%
Johnson & Johnson 14,000 1,270,587 2.668%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil